Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000621295 | SCV000735150 | likely benign | Cardiovascular phenotype | 2015-08-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001619809 | SCV001846671 | benign | not provided | 2019-08-06 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001700252 | SCV001917960 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001700252 | SCV001931068 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003980194 | SCV004791230 | benign | CACNA2D1-related disorder | 2019-06-26 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |